ArticleBMC genomics2025
Transcriptome analysis reveals key defense genes associated with resistance to banana blood disease.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundBananas are a globally significant crop, but their production is threatened by banana blood disease (BBD), caused by Ralstonia syzygii subsp. celebesensis (Rsc). While resistant cultivars like 'Khai Pra Ta Bong' (AAA genome) have been identified, the genetic basis of resistance remains unclear. This study uses RNA sequencing (RNA-seq) to investigate gene expression changes in 'Khai Pra Ta Bong' over seven days post-infection with Rsc isolate MY4101. Candidate genes associated with resistance were also evaluated in other cultivars, including resistant, moderately resistant, and highly susceptible cultivars.
resultsRNA-seq analysis identified several genes associated with BBD resistance mechanisms, showing significant upregulation as early as 12 h post-inoculation. Key molecular processes, including xyloglucan endotransglucosylase hydrolases, receptor-like kinases, and glycine-rich proteins, were enriched at 24 h post-inoculation, highlighting the activation of effector-triggered immunity (ETI). Quantitative real-time RT-PCR (qRT-PCR) validation further confirmed the differential expression of several key defense-related genes in other banana cultivars.
conclusionsThe study highlights the potential of these differentially expressed genes as genetic markers for BBD resistance, which could be valuable for breeding programs aimed at enhancing resistance in banana cultivars. These findings provide important insights into the molecular mechanisms of disease resistance and contribute to developing more efficient strategies for sustainable banana production and global food security.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.